Carla Geovanna Lever-Megina

Ms. Carla Geovanna Lever-Megina


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
ERElena Rescalvo-Fernández
Elena Rescalvo-Fernández
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
MMMaría Medrano
María Medrano
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
ASAlicia Saz-Lara
Alicia Saz-Lara
Objectives: This study aimed to examine the association between the visceral adiposity index and arterial stiffness in healthy adults via original data from the EVasCu study and to contextualize these findings through a meta-analysis of previously published studies in the general population. Methods: A cross-sectional analysis was conducted in 389 healthy adults from the EVasCu study. The visceral adiposity index was calculated on the basis of waist circumference, body mass index, triglycerides, and high-density lipoprotein cholesterol, integrating the anthropometric and metabolic components of visceral adiposity. Arterial stiffness was assessed by the aortic pulse wave velocity. These original findings were complemented by a meta-analysis, including EVasCu data and data from prior studies, to obtain pooled correlation coefficients and 95% confidence intervals (CIs) for the association between visceral adiposity and arterial stiffness. Results: In the EVasCu study, the visceral adiposity index showed a statistically significant moderate correlation with the aortic pulse wave velocity (r = 0.281, p < 0.001). In the meta-analysis, the pooled correlation coefficient was 0.34 (95% CI: 0.27, 0.42), supporting a consistent association between the visceral adiposity index and both central and peripheral arterial stiffness across diverse populations. Conclusions: These findings indicate a positive association between the visceral adiposity index and arterial stiffness in both healthy individuals and populations with cardiometabolic conditions. However, given the predominantly cross-sectional nature of the evidence and the heterogeneity among the included studies, the results should be interpreted with caution. Further longitudinal, multivariable, and mechanistic studies are needed to clarify the clinical relevance of the visceral adiposity index beyond correlation and to determine its potential role as a complementary marker in cardiovascular risk assessment.

ASAlicia Saz-Lara
Alicia Saz-Lara
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
EGEva Galan-Moya
Eva Galan-Moya
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
IOIris Otero-Luis
Iris Otero-Luis
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Recent evidence suggests that sex-related differences in cardiovascular health extend beyond traditional risk factors, affecting vascular structure and function. This study aimed to examine sex differences in vascular parameters, including central and peripheral blood pressure, pulse wave velocity (PWv), augmentation index at 75 bpm (AIx75), cardiac output, stroke volume, and peripheral vascular resistance, using harmonized data from three population-based cohorts (EVasCu, VascuNET, and ExIC-FEp) as part of the MUJER-EVA project. A total of 669 adult participants were included in this pooled cross-sectional analysis. Sex-stratified comparisons were conducted using multiple linear regression models adjusted for anthropometric, sociodemographic, and clinical covariates. The results showed that men had significantly higher values for central and peripheral blood pressure (p < 0.001), PWv (p = 0.003), cardiac output (p < 0.001), and stroke volume (p < 0.001), whereas women presented higher values of AIx75 (p < 0.001) and peripheral vascular resistance (p = 0.002). These differences remained statistically significant after full adjustment for potential confounders. These findings highlight the need to consider sex as a key biological variable in cardiovascular research and clinical decision-making. Incorporating sex-specific reference values and personalized treatment strategies could improve vascular health assessment and the effectiveness of cardiovascular disease prevention.